Sign up for free insights newsletter
30

CSPC Innovation Pharmaceutical Co Ltd Class A

300765SHE

Need professional-grade analysis? Visit stockanalysis.com

CN¥32.87
-3.32%
End of day
Market Cap

$45.73B

P/E Ratio

N/A

Employees

2,369

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino29.067.16-0.89-0.88-0.592.28
Calmar29.74-1.23-1.05-0.433.53
Sharpe9.623.10-0.60-0.58-0.360.66
Omega2.431.510.890.920.981.11
Martin71.04-1.80-1.75-0.709.01
Ulcer1.663.6326.7423.5533.7723.48

CSPC Innovation Pharmaceutical Co Ltd Class A (300765) Price Performance

CSPC Innovation Pharmaceutical Co Ltd Class A (300765) trades on SHE in CNY. The company is classified in the Consumer Defensive sector under the Packaged Foods industry. The stock currently trades at CNY32.87, down 3.32% from the previous close.

Over the past year, 300765 has traded between a low of CNY28.16 and a high of CNY63.00. The stock has lost 28.5% over this period. It is currently 47.8% below its 52-week high.

CSPC Innovation Pharmaceutical Co Ltd Class A has a market capitalization of $45.73B.

About CSPC Innovation Pharmaceutical Co Ltd Class A

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

Compare CSPC Innovation Pharmaceutical Co Ltd Class A

Side-by-side comparison against top Consumer Defensive peers.

Company Info

Exchange
SHE
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$2.16B
EBITDA
$-403,573,024
Profit Margin
-11.18%
EPS (TTM)
-0.17
Book Value
1.92

Technical Indicators

52 Week High
CN¥63.31
52 Week Low
CN¥27.83
50 Day MA
CN¥32.40
200 Day MA
CN¥40.36
Beta
0.30

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
21.20
Price/Book
17.90
Enterprise Value
$46.60B